Liver Embolization Approaches for Tumor Management
About this study
The goal of this evaluate short, medium and long term outcome of the different embolization techniques in patients with primary and secondary hepatic tumors. The main aim is to evaluate progression free survival following embolization in this study population or evaluate residual hepatic volume in cases in which these techniques are used to induce liver regeneration. This study is an observational registry - all patients will follow their normal therapeutic and treatment scheme as per clinical practice, without any additional intervention.
- Condition
- Hepatocellular Carcinoma, Cholangiocarcinoma, Metastatic Colon Cancer, Metastatic Cancer, Metastatic Gastric Cancer, Primary Liver Cancer, Metastatic Pancreatic Cancer
- Tested
- Embolization
- Sponsor
- IRCCS San Raffaele
Who can join
- Age
- 18 years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 6
- Minimum age: 18 years
- Study condition: Hepatocellular Carcinoma, Cholangiocarcinoma, Metastatic Colon Cancer, Metastatic Cancer, Metastatic Gastric Cancer, Primary Liver Cancer, Metastatic Pancreatic Cancer
- ≥ 18 yoa
- patients with patients with primary or secondary liver disease not amenable for surgery or ablation
- patients with primary or secondary liver tumors candidates for major surgery prior to induction of hypertrophy
- able and willing to sign informed consent
Exclusion 5
- pregnant women
- patients with uncorrectable coagulopathy
- diffuse extrahepatic disease
- for lobar TACE and TARE - presence of bilodigestive shunt
- for TARE - \>20% hepatopulmonary shunt
Where
1 site, 1 recruiting
IRCCS Ospedale San Raffaele
Milan, Italy
Contact
-
Francesco De Cobelli, MD
+39022643 trialcliniciradiologia@hsr.it
-
Stephanie Steidler, PhD
+39022643 steidler.stephanie@hsr.it
Potential match only. Final eligibility is determined by the study team.